Building better antibodies in pursuit of a broad-spectrum vaccine with Jacob Glanville
Release Date:
In this podcast we’re pleased to welcome Jacob Glanville, the CEO of Centivax. He is working on a single, broad-spectrum vaccine, initially for the flu.
Building better antibodies in pursuit of a broad-spectrum vaccine with Jacob Glanville